(CDMO) |
| 0 (0%) 04-14 05:00 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 13.08 |
| Resistance 1: | 11.20 |
| Pivot price: | 10.79 |
| Support 1: | 10.72 |
| Support 2: | 10.43 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 1.200 |
| Book Value | 11.680 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.997 |
| Profit Margin (%) | 59.99 |
| Operating Margin (%) | 86.32 |
| Return on Assets (ttm) | 4.8 |
| Return on Equity (ttm) | 10.1 |
Company news
Tue, 14 Apr 2026
March 2026 — CDMO Opportunities And Threats Report - Bioprocess Online
Mon, 13 Apr 2026
Andelyn Biosciences Highlights Collaborative CDMO Model With OneTeam Webinar - TipRanks
Mon, 13 Apr 2026
Icelandirect expands CDMO footprint with SOMA LABS solid dosage acquisition - NutraIngredients.com
Mon, 13 Apr 2026
Small Molecule Innovator API CDMO Market Outlook, 2026-2033 - Lonza Group, Novo Holdings (Catalent) and Thermo Fisher Scientific Lead the Growing Industry - Yahoo Finance
Fri, 10 Apr 2026
Cracking the Code for a Successful Partnership with a CDMO - Medical Device and Diagnostic industry
Fri, 10 Apr 2026
CDMO Arterex upgrades manufacturing facility near Boston - Medical Design & Outsourcing
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
